3D Imaging of Hard and Soft Tissue in Orthognathic Surgery
An Analysis of the Clinical Applicability of a Three-Dimensional Imaging Platform Used to Register the Influence of Orthognathic Surgery on Facial Hard and Soft Tissue in Patients With Congenital Maxillofacial Deformities.
1 other identifier
interventional
450
1 country
3
Brief Summary
The primary objective of this clinical trial is to assess the influence of orthognathic surgery on facial soft tissue, such as changes (volume, linear, angular) of facial hard and soft tissue, in three dimensions, so enabling the setup of 3D normative value tables.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2006
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 1, 2006
CompletedStudy Start
First participant enrolled
February 1, 2006
CompletedFirst Posted
Study publicly available on registry
February 2, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedJuly 27, 2007
July 1, 2007
February 1, 2006
July 26, 2007
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
All changes (volumetric, linear or angular) of facial hard and soft tissue caused by orthognathic surgery at 1 months, 6 months, 12 months and 24 months.
Secondary Outcomes (3)
All postoperative changes in functionality at 1 year
patients' satisfaction of facial proportions at 1 year
surgeons' satisfaction of the 3D planning platform at 1 month
Interventions
Eligibility Criteria
You may qualify if:
- Dysgnathic deformity
- Caucasian
- \> 15 years
- No history of orthognathic surgery
- Informed Consent
You may not qualify if:
- \< 15 years
- History of Orthognathic surgery
- Not Caucasian
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Rijnstate Hospital
Arnhem, 6815 AD, Netherlands
Hospital Gelderse Vallei
Ede, 6716 RP, Netherlands
Radboud University Nijmegen Medical Centre
Nijmegen, 6500 HB, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Stefaan J Bergé, Prof, MD, DMD, PhD,
Radboud University Medical Center
- PRINCIPAL INVESTIGATOR
Filip AC Schutyser, MsC
Radboud University Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 1, 2006
First Posted
February 2, 2006
Study Start
February 1, 2006
Study Completion
December 1, 2010
Last Updated
July 27, 2007
Record last verified: 2007-07